MaysAliMD Profile Banner
Mays Ali MD Profile
Mays Ali MD

@MaysAliMD

Followers
2K
Following
4K
Media
131
Statuses
1K

Assistant professor & cardiologist @MayoClinicCV. Wife. Mom. Passionate about #echo, #HCM and #meded. Views my own. #WIC πŸ‡ΊπŸ‡² πŸ‡¨πŸ‡¦

Jacksonville, FL
Joined April 2013
Don't wanna be here? Send us removal request.
@DrCatharineY
Dr. Catharine Young
1 year
Perspective is everything.
16
246
2K
@MayoClinicCV
Mayo Clinic CV
1 year
One week left to save $100 on the @MayoClinic Echo Revolution #CME course! Our course directors @pattypellikka and @mdmankad have developed a world-class lineup of faculty and a robust program covering many aspects of #Echocardiography. Register today: https://t.co/7kM1ZUDl6o
2
5
10
@MayoClinicCV
Mayo Clinic CV
1 year
What are indications to use ultrasound enhancement agent (#UEA) in your clinical practice? On today's #CardiovascularCME Podcast, guests @JeremyThaden and @MaysAliMD sit down with host @KyleWKlarich to answer this question and more:
0
5
8
@MayoClinicCV
Mayo Clinic CV
1 year
We made so many great connections at #ESCCongress in London over the last 4 days. Cheers to @escardio for organizing such an amazing event. We were thrilled to connect with cardiologists from all over the world along with many of our own @MayoClinic colleagues.
0
6
22
@SahilBloom
Sahil Bloom
1 year
This image hit me hard... I think of this as the Beginner's Paradox: You have to start poorly to end well. The most successful people I know love the feeling of being an embarrassing beginner. They thrive on that feeling of newness. They love diving into something with a
83
217
2K
@ASE360
American Society of Echocardiography
1 year
The mechanism of left ventricular outflow tract obstruction (LVOTO) is complex in hypertrophic cardiomyopathy (HCM). We aimed to evaluate the impact of mitral valve geometry on LVOTO by echocardiography. Read our @JournalASEcho article: https://t.co/fSjQ9fZFkO
3
122
326
@JACCJournals
JACC Journals
1 year
In the VALOR-HCM placebo-controlled trial of #mavacamten for symptomatic obstructive #cvHCM hypertrophic cardiomyopathy, mavacamten improved mitral valve SAM and regurgitation. https://t.co/4U6AwzvceK #JACCIMG @PaulCremerMD @DesaiMilindY @jeffreygeske
1
11
33
@MayoClinicCVS
Mayo Clinic Cardiac Surgery
1 year
Experts from @MayoClinic in HCM, @jeffreygeske, @SteveOmmen & @HSchaffMD, discuss the recent publication of the "2024 AHA/ACC/AMSSM/HRS/PACES/SCMR Guideline for the Management of Hypertrophic Cardiomyopathy". https://t.co/9JfD7wURa5
0
7
16
@mydocwire
DocWire News
1 year
πŸ†• @AmitGoyalMD details the bRIGHT study, which offers a valuable glimpse into the real-world performance of the Abbott TriClip device. @CardioNerds #interventionalcardiology #cardiology #cardiotwitter #cardioX Read Now❗: https://t.co/ihtvgJeiod
0
8
9
@CarlosVergaraMD
Carlos Vergara MD
1 year
What an honor and privilege, this lecture was just incredible! The learning experience in the FIT leadership academy is beyond I ever expected. Thank you Dr Kusumoto and to all the atendees. See you next month with Dr @RheaSancassani @ACCinTouch @FloridaACC #FITLeadership
1
1
35
@MayraGuerreroMD
Mayra Guerrero, MD
1 year
We enrolled Intermediate surgical risk patient in the Mitral Valve-in-Valve Registry of PARTNER 3 trial. A total fo 50 patients were treated with TS MViV using the Sapien 3 THV, mean age 70 years, 54% female and mean STS-PROM of 4.1%. Technical success was 98%. The 26 mm S3 and
1
8
46
@pattypellikka
Dr.Patricia Pellikka
1 year
An #AI model to detect HFpEF from an apical 4Ch video identified pts with increased risk of hospitalization for HF and cardiac mortality @MayoClinicCV @Ultromics @JournalASEcho Automated Echocardiographic Detection of Heart Failure With Preserved ...
0
12
30
@EJHFEiC
EJHF Editor-in-Chief
1 year
In a 36-wk study on #Aficamten for nHCM , 82.3% of pts reached 15–20mg/d with significant improvement in NYHA , KCCQ score, & #NTproBNP levels Read the full πŸ“ in this short report by @MasriAhmadMD et al. https://t.co/RdXjuh7QKE #EJHF @GiuseppeGalati_ @AmrAbdin10 @HanCardiomd
0
10
24
@JAHA_AHA
JAHA
1 year
Aspirin use for primary prevention is so last decade. But maybe it should be? Read how quantification of subclinical carotid atherosclerosis may help improve allocation of aspirin. #AHAJournals @OmarDzaye @MichaelJBlaha @CiccaroneCenter https://t.co/WVmHl5hMbh
0
5
8
@DemiladeMD
Demi Adedinsewo, MD
1 year
Excited to share a new πŸ—žοΈ published in @CircAHA this week! Grateful for the opportunity to contribute to this important conversation on #AI for #HealthEquity https://t.co/nrDNKKGTFZ @MayoClinicCV
0
6
23
@MaysAliMD
Mays Ali MD
1 year
Standing room only @MayoClinic FL Medical Grand Rounds as my friend & colleague @AwaisMalikMD takes the stage to present on #cardiacamyloidosis! An excellent overview of when to suspect cardiac amyloid, diagnostic criteria (notable mention @DanDaviesMD's risk score) & management.
0
4
26
@ASE360
American Society of Echocardiography
1 year
UPCOMING WEBINAR: Join us for the webinar, "Evaluation of Mitral Valve Prosthesis by Echocardiography," on August 22 at 6-7 PM ET! πŸ«€ Sign up: https://t.co/gmQEOhipcv
1
29
90
@DermotPhelanMD
Dermot Phelan
1 year
The sudden cardiac arrest (SCA) or death of a young athlete impacts beyond sports. High-profile cases like @HamlinIsland & @BronnyJamesJr highlight the need for action. βœ…Mandatory CPR training for all sports coaches
1
12
55
@rblument1
Roger Blumenthal
1 year
Life’s Necessary 9! Ignoring Mental Well-Being Is Costing Lives: Is it Time... https://t.co/6bajAJixiN Outstanding work by @AdhyaMehtaMD & @DrRishiC @CiccaroneCenter @hopkinsheart @HopkinsMedicine @TLeucker #πŸ₯πŸβ›³οΈπŸ€βšΎοΈ
2
7
22